These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 4776405)
1. [Problem of cumulative properties of the antineoplastic antibiotic 1719]. Goldberg LE; Filippos'iants ST; Stepanova ES Antibiotiki; 1973 Aug; 18(8):701-6. PubMed ID: 4776405 [No Abstract] [Full Text] [Related]
2. [Method of determination of cumulative properties of drugs]. Gol'dberg LE; Baumshteĭn VE Farmakol Toksikol; 1969; 32(2):222-6. PubMed ID: 5772152 [No Abstract] [Full Text] [Related]
3. [Study of the toxicity and pharmacological properties of the new antibiotic lienomycin]. Filippos'iants ST; Gol'dberg LE; Stepanova ES; Belova IP; Kunrat IA Antibiotiki; 1971 Jul; 16(7):604-9. PubMed ID: 5157509 [No Abstract] [Full Text] [Related]
4. [Studies on antitumor antibiotic 1588--IV. Metabolism and toxicity studies]. Yang GZ Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):5-7. PubMed ID: 6189686 [No Abstract] [Full Text] [Related]
5. [Pharmacological properties of 20 antibiotic isolated from Aspergillus fumigatus]. Syrkin AB; Plotnikov NP; Zaĭtseva LA; Bodiagin DA Antibiotiki; 1969 Jun; 14(6):522-5. PubMed ID: 5805635 [No Abstract] [Full Text] [Related]
6. Cancer chemotherapy. Studies on anticancer agents particularly anticancer antibiotics. Hata T Kitasato Arch Exp Med; 1971 Dec; 44(3):135-54. PubMed ID: 5155554 [No Abstract] [Full Text] [Related]
7. [Study of the effect of the antibiotic rubomycin C in combination with prodigiozan on some defense reactions of the organism]. Artemova LK Antibiotiki; 1970 Mar; 15(3):263-6. PubMed ID: 4911268 [No Abstract] [Full Text] [Related]
8. Biological studies on bleomycin A. Ichikawa T; Matsuda A; Miyamoto K; Tsubosaki M; Umezawa H J Antibiot (Tokyo); 1967 Jul; 20(3):149-55. PubMed ID: 6072795 [No Abstract] [Full Text] [Related]
9. [Pharmacological examination of the antibiotic brneomycin]. Gol'dberg LE; Baumshteĭn VE Antibiotiki; 1967 Feb; 12(2):132-40. PubMed ID: 5590098 [No Abstract] [Full Text] [Related]
10. The disposition of the antitumor agent, sangivamycin, in mice. Hardesty CT; Chaney NA; Waravdekar VS; Mead JA Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899 [No Abstract] [Full Text] [Related]
11. [Data on toxicity and individual therapy results on anti-neoplastic antibiotics in the dog]. Stein E Tierarztl Prax; 1973; 1(4):445-56. PubMed ID: 4806282 [No Abstract] [Full Text] [Related]
12. [Production conditions and properties of the new antineoplastic antibiotic No. 294]. Brazhnikova MG; Kudinova MK; Vishniakova IA; Gauze GF; Preobrazhenskaia TP Antibiotiki; 1970 Aug; 15(8):675-8. PubMed ID: 5537044 [No Abstract] [Full Text] [Related]
13. [Effect of the purified antibiotic neocid on the peripheral blood of laboratory animals]. Derkach EM Antibiotiki; 1970 Mar; 15(3):274-6. PubMed ID: 5447130 [No Abstract] [Full Text] [Related]
15. [Experimental study of the antimicrobial properties and antineoplastic effect of the new pentaenic antibiotic 661]. Rossolimo OK; Ivanitskaia LP; Kovsharova IN; Konstantinova NV; Lavrova MF Antibiotiki; 1969 Sep; 14(9):849-52. PubMed ID: 4982966 [No Abstract] [Full Text] [Related]
16. [Use of the probit method for the evaluation of the effectiveness of rubomycin in the treatment of transplantable tumors in mice]. Bazhanov VS Antibiotiki; 1971; 16(8):714-8. PubMed ID: 5171848 [No Abstract] [Full Text] [Related]
17. [An experimental study of the antineoplastic action of the antibiotic rubomycin]. Shorin VA; Rossolimo OK; Stanislavskaia MS; Bliumberg NA; Lepeshkina GN Antibiotiki; 1966 Jan; 11(1):14-20. PubMed ID: 6013318 [No Abstract] [Full Text] [Related]